DFTX
Held · Bookmarked
0 · 0
portfolios · users
Platform exposure
—
13F filers
0
institutions
Market cap
$2.7B
109M shares
52-week range
$14.62 – $39.16
79% from low
Sector
MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
Exchange
NASDAQ
CS
Borrow rate
0.40%
Easy to borrow
Price (6 mo)
Definium Therapeutics, Inc. Common Shares
Definium Therapeutics Inc is developing inventive, next-generation therapeutics intended to solve the underlying causes of psychiatric and neurological disorders and offer patients long-term remission rather than transient symptom reduction. Its late-stage pipeline includes four Phase 3 trials-two each for GAD and MDD-anchored by its candidate, DT120 ODT, which has received FDA Breakthrough Therapy Designation for GAD. In parallel, the Company is advancing its commercial and operational readiness to support a care model and prepare for the potential launch of DT120 ODT, if approved and marketed. The company operates in one reportable segment relating to the research and development of the company's neurological drug development platform.
www.definiumtx.com- Employees
- 106
- IPO / List date
- Mar 3, 2020
- HQ
- NEW YORK, NY
Held by traders on TradeandTell
No one on the platform currently holds DFTX.
Super investors & insiders
No tracked institution reports a position in DFTX as of their last filing.
- Form 4 filed Jun 22, 2026↗
- Form 4 filed Jun 22, 2026↗
- Form 4 filed Jun 22, 2026↗
- Form 4 filed Jun 22, 2026↗
- Form 4 filed Jun 22, 2026↗
- Form 4 filed Jun 15, 2026↗
- Form 4 filed Jun 15, 2026↗
- Form 4 filed Jun 15, 2026↗
- Form 4 filed Jun 15, 2026↗
- Form 4 filed Jun 15, 2026↗
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
Recent trades on TradeandTell
No one on the platform has traded DFTX yet.
$DFTX chatter on StockTwits
👀Some Stocks to Watch for 23 June: CIIT VTAK ORIS ADTX MGRX $IONR $INFQ $SKYQ $DFTX $CDT 💪Below is from yesterday's Alerts and June's Top Alerts. 👉Come Join us for profits and learning how to get those profits. 💰4th of July Sale going on now.
View on StockTwits ↗
Still holding $DFTX $VG $FOX $KLAC. The market is pricing in breakout vs rejection debate, but I think the longer-term story is still developing.
View on StockTwits ↗
🚀 Bulls stacking wins on Monday June 22 with biotech catalysts, small-cap volume surges, and AI infrastructure momentum! 🐂📈 First off 😎 who’s all up late studying charts and getting ready for tomorrow? Our group just received two new banger alerts that have serious 100-200% run potential. Eyes sharp, bulls! Huge congrats to everyone riding these top 5 movers today. $APGE +46.7% – Apogee Therapeutics surging on positive biotech pipeline news and strong institutional buying. $DFTX +49.8% – Definium Therapeutics exploding on clinical catalyst and speculative small-cap momentum. $SMCI + momentum – Super Micro Computer lifting on new AI data center blueprint with Nvidia tech. $ORKA +18% – Oruka Therapeutics climbing on healthcare sector rotation and volume surge. $HQ +20% – Horizon Quantum Holdings gaining on quantum/AI interest and breakout action. Solid start to the week with resilience, bulls 😎 #TopMovers #BullMarket #Stocks #BangerAlerts #BiotechRally
View on StockTwits ↗
$DFTX Notice in the filing that they are offering "common shares and pre-funded warrants." Pre-funded warrants are essentially stealth shares. Institutions buy them so they don't trigger the regulatory rule where they have to report owning more than 4.99% or 9.99% of the company. They sit on those warrants, wait for retail to drive the price back up, and exercise them into common stock to dump on the open market.
View on StockTwits ↗$DFTX Check the math, bulls. 🧮 Before yesterday's "Emerge" data pump, the OS was sitting at 104M shares. Barrow is dumping a $500M block (+ $75M option) directly onto the market. Even if Wall Street is generous and prices this at a "discounted" $30.00, that adds nearly 19.2 MILLION new shares to the pool. 💸 That is a massive ~18% immediate dilution to your position. Every dollar of profit this company might make in 2028 just got sliced up to feed J.P. Morgan and BofA Securities. They used your Phase 3 excitement to expand the float by a fifth overnight. 🤡 This is why you don't hold bio-techs through data calls. Exit liquidity achieved. 🚮 #FloatExpansion #MathDontLie #BarrowPrintedPaper #Short
View on StockTwits ↗
I am seeing earnings reaction watch in $ACN $DFTX $KEEL $CRDO. Not reacting emotionally, just observing price action and volume behavior across sessions.
View on StockTwits ↗
$DFTX It's too early to say it's overpriced. They just exceeded expectations with the MDD results. There was no Phase 1 or Phase 2. They went straight to Phase 3 and outperformed. In the next three months there will be two more trial results. Definitely too early to say it's overpriced. Good results and they could own GAD.
View on StockTwits ↗
$DFTX lol i love that when good results come out the bears come out literally no spamming or anything for the past months and now they are all sorry
View on StockTwits ↗$DFTX OMG, I bought right before close and they pull this! Is this legal?
View on StockTwits ↗
$IBIT $DFTX is trading in a way that reflects institutional accumulation signal. I am staying disciplined and letting the chart confirm the narrative.
View on StockTwits ↗
$DFTX so they pumped it all Day and then right before closing they announce the offering?! Is that legal? Why didn’t they announce the offering this morning with the data? Thanks crazy to do in the same Day. They don’t even care. Lol
View on StockTwits ↗
Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.